Funds holding “AbbVie Inc”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
50 positions across 42 funds, 15 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| BME BlackRock Health Sciences Trust Healthcare | AbbVie Inc | 00287Y109 | EC | 5.06% | $29M | Jun 30, 2026 | full (152 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | ABBVIE INC | 00287Y109 | EC | 2.63% | $6M | Jun 30, 2026 | full (195 positions) |
| ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund U.S. Equity | AbbVie Inc | 00287Y109 | EC | 2.06% | $12.7M | Jun 30, 2026 | full (59 positions) |
| ETY Eaton Vance Tax-Managed Diversified Equity Income Fund U.S. Equity | AbbVie Inc | 00287Y109 | EC | 2.05% | $51.4M | Jul 31, 2026 | full (58 positions) |
| EOS Eaton Vance Enhanced Equity Income Fund II Covered Call / Option Income | AbbVie Inc | 00287Y109 | EC | 2.03% | $26.1M | Jun 30, 2026 | full (88 positions) |
| EOI Eaton Vance Enhanced Equity Income Fund Covered Call / Option Income | AbbVie Inc | 00287Y109 | EC | 1.96% | $17M | Jun 30, 2026 | full (108 positions) |
| THQ abrdn Healthcare Opportunities Fund Healthcare | AbbVie Inc | 00287Y109 | EC | 1.94% | $20.4M | Jun 30, 2026 | full (109 positions) |
| FFA First Trust Enhanced Equity Income Fund Covered Call / Option Income | ABBVIE INC | 00287Y109 | EC | 1.85% | $9.1M | Jun 30, 2026 | full (84 positions) |
| NFJ Virtus Dividend, Interest & Premium Strategy Fund U.S. Equity | ABBVIE INC | 00287Y109 | EC | 1.66% | $24.6M | Jul 31, 2026 | full (170 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | AbbVie Inc | 00287Y109 | EC | 1.58% | $17.1M | Jun 30, 2026 | full (170 positions) |
| IGD Voya Global Equity Dividend & Premium Opportunity Fund Global Equity | ABBVIE INC | 00287Y109 | EC | 1.33% | $6.5M | May 31, 2026 | full (249 positions) |
| IGA Voya Global Advantage & Premium Opportunity Fund Multi-Asset | ABBVIE INC | 00287Y109 | EC | 1.33% | $2.1M | May 31, 2026 | full (249 positions) |
| AOD abrdn Total Dynamic Dividend Fund U.S. Equity | AbbVie Inc | 00287Y109 | EC | 1.31% | $14.7M | Jul 31, 2026 | full (86 positions) |
| AGD abrdn Global Dynamic Dividend Fund Global Equity | AbbVie Inc | 00287Y109 | EC | 1.22% | $3.9M | Jul 31, 2026 | full (88 positions) |
| EVT Eaton Vance Tax-Advantaged Dividend Income Fund U.S. Equity | AbbVie Inc | 00287Y109 | EC | 1.21% | $37.3M | Jul 31, 2026 | full (155 positions) |
| CLM Cornerstone Strategic Investment Fund Multi-Asset | ABBVIE INC | 00287Y109 | EC | 0.96% | $19.1M | Jun 30, 2026 | full (113 positions) |
| CRF Cornerstone Total Return Fund Multi-Asset | ABBVIE INC | 00287Y109 | EC | 0.95% | $10.1M | Jun 30, 2026 | full (101 positions) |
| BBN BlackRock Taxable Municipal Bond Trust Municipal Bonds | ABBVIE INC | 00287YEG0 | DBT | 0.90% | $9.2M | Jun 30, 2026 | full (238 positions) |
| TBLD Thornburg Income Builder Opportunities Trust Multi-Asset | AbbVie Inc | 00287Y109 | EC | 0.86% | $6.3M | Jun 30, 2026 | full (207 positions) |
| TY Tri-Continental Corp U.S. Equity | AbbVie Inc | 00287Y109 | EC | 0.83% | $17.1M | Jun 30, 2026 | full (240 positions) |
| ETB Eaton Vance Tax-Managed Buy-Write Income Fund Covered Call / Option Income | AbbVie Inc | 00287Y109 | EC | 0.74% | $3.7M | Jun 30, 2026 | full (133 positions) |
| SPXX Nuveen S&P 500 Dynamic Overwrite Fund Covered Call / Option Income | AbbVie Inc | 00287Y109 | EC | 0.68% | $19.6M | Jun 30, 2026 | full (556 positions) |
| ECAT BlackRock ESG Capital Allocation Term Trust U.S. Equity | AbbVie Inc | 00287Y109 | EC | 0.59% | $9.8M | Jun 30, 2026 | full (1,193 positions) |
| HEQ John Hancock Diversified Income Fund Multi-Asset | AbbVie Inc. | 00287Y109 | EC | 0.52% | $856K | Jun 30, 2026 | full (654 positions) |
| SCD LMP Capital & Income Fund U.S. Equity | ABBVIE INC | 00287Y109 | EC | 0.52% | $2.6M | May 29, 2026 | full (169 positions) |
| ETW Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund Covered Call / Option Income | AbbVie Inc | 00287Y109 | EC | 0.52% | $6M | Jun 30, 2026 | full (258 positions) |
| CSQ Calamos Strategic Total Return Fund Multi-Asset | AbbVie Inc | 00287Y109 | EC | 0.45% | $21.9M | Jul 31, 2026 | full (820 positions) |
| THW abrdn World Healthcare Fund Healthcare | ABBVIE INC | 00287YAR0 | DBT | 0.45% | $3.1M | Jun 30, 2026 | full (131 positions) |
| BTZ BlackRock Credit Allocation Income Trust Taxable Bonds | ABBVIE INC | 00287YDB2 | DBT | 0.42% | $5M | Jun 30, 2026 | full (1,766 positions) |
| BCAT BlackRock Capital Allocation Term Trust U.S. Equity | AbbVie Inc | 00287Y109 | EC | 0.42% | $7M | Jun 30, 2026 | full (1,148 positions) |
| BHK BlackRock Core Bond Trust Investment Grade | ABBVIE INC | 00287YBD0 | DBT | 0.27% | $1.9M | Jun 30, 2026 | full (1,422 positions) |
| WEA Western Asset Premier Bond Fund Taxable Bonds | ABBVIE INC | 00287YDU0 | DBT | 0.27% | $506K | Jun 30, 2026 | full (384 positions) |
| TY Tri-Continental Corp U.S. Equity | ABBVIE INC | 00287YEB1 | DBT | 0.26% | $5.4M | Jun 30, 2026 | full (240 positions) |
| THQ abrdn Healthcare Opportunities Fund Healthcare | ABBVIE INC | 00287YAW9 | DBT | 0.25% | $2.6M | Jun 30, 2026 | full (109 positions) |
| BTZ BlackRock Credit Allocation Income Trust Taxable Bonds | ABBVIE INC | 00287YAS8 | DBT | 0.25% | $2.9M | Jun 30, 2026 | full (1,766 positions) |
| THW abrdn World Healthcare Fund Healthcare | ABBVIE INC | 00287YAW9 | DBT | 0.21% | $1.5M | Jun 30, 2026 | full (131 positions) |
| JHS John Hancock Income Securities Trust Taxable Bonds | AbbVie Inc. | 00287YDU0 | DBT | 0.19% | $436K | Jul 31, 2026 | full (931 positions) |
| JCE Nuveen Core Equity Alpha Fund U.S. Equity | AbbVie Inc | 00287Y109 | EC | 0.15% | $450K | Jun 30, 2026 | full (144 positions) |
| GDV Gabelli Dividend & Income Trust U.S. Equity | ABBVIE INC | 00287Y109 | EC | 0.14% | $4.7M | Jun 30, 2026 | full (729 positions) |
| BHK BlackRock Core Bond Trust Investment Grade | ABBVIE INC | 00287YAV1 | DBT | 0.14% | $944K | Jun 30, 2026 | full (1,422 positions) |
| ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund Covered Call / Option Income | AbbVie Inc | 00287Y109 | EC | 0.09% | $1.6M | Jun 30, 2026 | full (147 positions) |
| MMT Aberdeen Multi-Market Income Fund Taxable Bonds | ABBVIE INC | 00287YEF2 | DBT | 0.06% | $455K | Jul 31, 2026 | full (875 positions) |
| MMT Aberdeen Multi-Market Income Fund Taxable Bonds | ABBVIE INC | 00287YDV8 | DBT | 0.06% | $438K | Jul 31, 2026 | full (875 positions) |
| JHS John Hancock Income Securities Trust Taxable Bonds | AbbVie Inc. | 00287YEF2 | DBT | 0.05% | $111K | Jul 31, 2026 | full (931 positions) |
| MMT Aberdeen Multi-Market Income Fund Taxable Bonds | ABBVIE INC | 00287YDW6 | DBT | 0.04% | $305K | Jul 31, 2026 | full (875 positions) |
| GOF Guggenheim Strategic Opportunities Fund Multi-Asset | ABBVIE INC | 00287Y109 | EC | 0.04% | $1.1M | May 29, 2026 | full (1,841 positions) |
| VBF Invesco Bond Fund Taxable Bonds | AbbVie Inc. | 00287YDX4 | DBT | 0.04% | $69.4K | May 31, 2026 | full (1,621 positions) |
| GAB Gabelli Equity Trust U.S. Equity | ABBVIE INC | 00287Y109 | EC | 0.00% | $37.7K | Jun 30, 2026 | full (709 positions) |
| GUG Guggenheim Active Allocation Fund U.S. Equity | ABBVIE INC-CVR | — | EC | 0.00% | $0 | May 29, 2026 | full (1,258 positions) |
| BRW Saba Capital Income & Opportunities Fund U.S. Equity | Abbvie Inc | 00287Y109 | EC | -0.01% | $-50.7K | Jul 31, 2026 | full (1,143 positions) |
Matching position names
ABBVIE INC · 24AbbVie Inc · 20AbbVie Inc. · 4ABBVIE INC-CVR · 1Abbvie Inc · 1
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.